Question 1

Has Roger Strunk received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,229 in general payments to Roger Strunk across 75 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Roger Strunk did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Roger Strunk come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie	18	$244
GSK	9	$155
Novo Nordisk	9	$149
Boehringer Ingelheim	6	$120
AstraZeneca	7	$117
Bayer	4	$72
Takeda Pharmaceuticals U.S.A., Inc.	3	$49
Biohaven Pharmaceutical Holding Company Ltd.	2	$44
Johnson & Johnson	2	$39
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$35
Merck	2	$34
Medtronic	2	$33
Amgen	2	$29
Kowa Pharmaceuticals America, Inc.	2	$28
Eisai Inc.	1	$20
Esperion Therapeutics, Inc.	1	$19
Biohaven Pharmaceuticals, Inc.	1	$17
Dexcom, Inc.	1	$14
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$12

Roger Strunk

Payments from drug & device makers

Who reported the general payments

How this compares

Other internal medicine in Frankfort